Composition for prevention or treatment of neuroinflammation, containing daphne genkwa flower bud extract as active ingredient

Abstract

The present disclosure relates to a composition for prevention or treatment of neuroinflammation, comprising a Daphne genkwa flower bud extract as an active ingredient. According to the present disclosure, the Daphne genkwa flower bud extract of the present disclosure exhibits anti-inflammatory activity in nerve cells and thus has an effect of inhibiting neuroinflammation, inhibits (hyper) activation of microglia, and prevents neuronal loss and promotes the proliferation of nerve cells, thereby protecting nerves, and thus may be used for the use of reducing neuroinflammatory disease, neurodegenerative disease, or microglial activation.

Dependencies are inferred from the claim text.